Abstract
The use of extracorporeal membrane oxygenation can be rationalised by the assumption that non-zero survival after refractory cardiorespiratory failure represents improved outcome. Survivors may have cognitive and or functional morbidities, require complex ongoing care, and as a consequence consume considerable healthcare resources.
MeSH terms
-
Costs and Cost Analysis / methods
-
Developmental Disabilities / economics
-
Developmental Disabilities / etiology
-
Economics, Hospital
-
Extracorporeal Membrane Oxygenation / economics
-
Extracorporeal Membrane Oxygenation / mortality*
-
Health Resources / economics
-
Humans
-
Infant, Newborn
-
Morbidity
-
Retrospective Studies
-
Treatment Outcome